UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Multiple Sclerosis: Diagnosis and Treatment II

Rivera, Víctor M

2022

Volltextzugriff (PDF)

Factors influencing serum neurofilament light chain levels in normal aging

Aging (Albany, NY.), 2021-12, Vol.13 (24), p.25729-25738

2021

Volltextzugriff (PDF)

The effect of alemtuzumab on neurodegeneration in relapsing-remitting multiple sclerosis: A five-year prospective mono-center study

Multiple sclerosis and related disorders, 2024-11, Vol.91, p.105894, Article 105894

2024

Volltextzugriff (PDF)

Neurofilament light chain plasma concentration predicts neurodegeneration and clinical progression in nondemented elderly adults

Aging (Albany, NY.), 2019-09, Vol.11 (17), p.6904-6914

2019

Volltextzugriff (PDF)

Serum neurofilament levels in patients with multiple sclerosis: A comparison of SIMOA and high sensitivity ELISA assays and contributing factors to ELISA levels

Multiple sclerosis and related disorders, 2022-11, Vol.67, p.104177-104177, Article 104177

2022

Volltextzugriff (PDF)

Changes in telomere length and serum neurofilament light chain levels in female patients with chronic insomnia disorder

Journal of clinical sleep medicine, 2022-02, Vol.18 (2), p.383-392

2022

Volltextzugriff (PDF)

Effect of Neurotoxin Exposure on Blood Biomarkers of Neurodegeneration and Alzheimer Disease

Alzheimer disease and associated disorders, 2023-10, Vol.37 (4), p.310-314

2023

Volltextzugriff (PDF)

High or increasing serum NfL is predictive of impending multiple sclerosis relapses

Multiple sclerosis and related disorders, 2022-03, Vol.59, p.103535-103535, Article 103535

2022

Volltextzugriff (PDF)

Combination of pathological, biochemical and behavioral evaluations for peripheral neurotoxicity assessment in isoniazid-treated rats

Journal of Toxicologic Pathology, 2023, pp.2023-0094

2023

Volltextzugriff (PDF)

Identifying the dataset to define the optimal timing of histopathological examination for central nervous system toxicity in MPTP-induced Parkinson’s disease monkey model

Journal of Toxicologic Pathology, 2023, pp.2023-0010

2023

Volltextzugriff (PDF)

Comparison of SIMOA and VEUS technologies for serum neurofilament light chain measurement in multiple sclerosis

Multiple sclerosis and related disorders, 2024-10, Vol.90, p.105815, Article 105815

2024

Volltextzugriff (PDF)

Interleukin-1 receptor antagonist: An exploratory plasma biomarker that correlates with disabilty and provides pathophysiological insights in relapsing-remitting multiple sclerosis

Multiple sclerosis and related disorders, 2021-07, Vol.52, p.103006

2021

Volltextzugriff (PDF)

Circulating levels of tight junction proteins in multiple sclerosis: Association with inflammation and disease activity before and after disease modifying therapy

Multiple sclerosis and related disorders, 2021-09, Vol.54, p.103136-103136, Article 103136

2021

Volltextzugriff (PDF)

Ultrasensitive immunoassay allows measurement of serum neurofilament heavy in multiple sclerosis

Multiple sclerosis and related disorders, 2021-05, Vol.50, p.102840-102840, Article 102840

2021

Volltextzugriff (PDF)

Targeting miR-381-NEFL axis sensitizes glioblastoma cells to temozolomide by regulating stemness factors and multidrug resistance factors

Oncotarget, 2015-02, Vol.6 (5), p.3147-3164

2015

Volltextzugriff (PDF)

Does serum neurofilament light chain measurement influence therapeutic decisions in multiple sclerosis?

Multiple sclerosis and related disorders, 2024-10, Vol.90, p.105838, Article 105838

2024

Volltextzugriff (PDF)

Serum NfL and GFAP are weak predictors of long-term multiple sclerosis prognosis: A 6-year follow-up

Multiple sclerosis and related disorders, 2024-09, Vol.89, p.105747, Article 105747

2024

Volltextzugriff (PDF)

The effect of aerobic exercise on Neurofilament light chain and glial Fibrillary acidic protein level in patients with relapsing remitting type multiple sclerosis

Multiple sclerosis and related disorders, 2021-10, Vol.55, p.103219-103219, Article 103219

2021

Volltextzugriff (PDF)

Prevalence of elevated sNFL in a real-world setting: Results on 908 patients with different multiple sclerosis types and treatment conditions

Multiple sclerosis and related disorders, 2024-08, Vol.88, p.105748, Article 105748

2024

Volltextzugriff (PDF)

Age-corrected neurofilament light chain ratio decreases but does not predict relapse in highly active multiple sclerosis patients initiating natalizumab treatment

Multiple sclerosis and related disorders, 2024-08, Vol.88, p.105701, Article 105701

2024

Volltextzugriff (PDF)

Brain-derived neurotrophic factor and neurofilament light chain in cerebrospinal fluid are inversely correlated with cognition in Multiple Sclerosis at the time of diagnosis

Multiple sclerosis and related disorders, 2022-07, Vol.63, p.103822-103822, Article 103822

2022

Volltextzugriff (PDF)

The interaction between exercise and neurofilament light chain in multiple sclerosis: a systematic review and meta-analysis

Multiple sclerosis and related disorders, 2024-10, Vol.90, p.105809, Article 105809

2024

Volltextzugriff (PDF)

Serum Neurofilaments are a reliable biomarker to early detect PML in Multiple Sclerosis patients

Multiple sclerosis and related disorders, 2023-09, Vol.77, p.104893-104893, Article 104893

2023

Volltextzugriff (PDF)

Evaluating the utility of serum NfL, GFAP, UCHL1 and tTAU as estimates of CSF levels and diagnostic instrument in neuroinflammation and multiple sclerosis

Multiple sclerosis and related disorders, 2024-07, Vol.87, p.105644, Article 105644

2024

Volltextzugriff (PDF)

The weak association between neurofilament levels at multiple sclerosis onset and cognitive performance after 9 years

Multiple sclerosis and related disorders, 2020-11, Vol.46, p.102534-102534, Article 102534

2020

Volltextzugriff (PDF)

1 – 25 von 88

Suche als RSS-Feed

Aktive Filter

Nur zeigenGeprüft (Peer-Review)

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Mit Volltextzugriff
(76)

Publikationsform

Sprache

Englisch
(83)
Chinesisch
(5)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Multiple Sclerosis: Diagnosis and Treatment II

Factors influencing serum neurofilament light chain levels in normal aging

The effect of alemtuzumab on neurodegeneration in relapsing-remitting multiple sclerosis: A five-year prospective mono-center study

Neurofilament light chain plasma concentration predicts neurodegeneration and clinical progression in nondemented elderly adults

Serum neurofilament levels in patients with multiple sclerosis: A comparison of SIMOA and high sensitivity ELISA assays and contributing factors to ELISA levels

Changes in telomere length and serum neurofilament light chain levels in female patients with chronic insomnia disorder

Effect of Neurotoxin Exposure on Blood Biomarkers of Neurodegeneration and Alzheimer Disease

High or increasing serum NfL is predictive of impending multiple sclerosis relapses

Combination of pathological, biochemical and behavioral evaluations for peripheral neurotoxicity assessment in isoniazid-treated rats

Identifying the dataset to define the optimal timing of histopathological examination for central nervous system toxicity in MPTP-induced Parkinson’s disease monkey model

Comparison of SIMOA and VEUS technologies for serum neurofilament light chain measurement in multiple sclerosis

Interleukin-1 receptor antagonist: An exploratory plasma biomarker that correlates with disabilty and provides pathophysiological insights in relapsing-remitting multiple sclerosis

Circulating levels of tight junction proteins in multiple sclerosis: Association with inflammation and disease activity before and after disease modifying therapy

Ultrasensitive immunoassay allows measurement of serum neurofilament heavy in multiple sclerosis

Targeting miR-381-NEFL axis sensitizes glioblastoma cells to temozolomide by regulating stemness factors and multidrug resistance factors

Does serum neurofilament light chain measurement influence therapeutic decisions in multiple sclerosis?

Serum NfL and GFAP are weak predictors of long-term multiple sclerosis prognosis: A 6-year follow-up

The effect of aerobic exercise on Neurofilament light chain and glial Fibrillary acidic protein level in patients with relapsing remitting type multiple sclerosis

Prevalence of elevated sNFL in a real-world setting: Results on 908 patients with different multiple sclerosis types and treatment conditions

Age-corrected neurofilament light chain ratio decreases but does not predict relapse in highly active multiple sclerosis patients initiating natalizumab treatment

Brain-derived neurotrophic factor and neurofilament light chain in cerebrospinal fluid are inversely correlated with cognition in Multiple Sclerosis at the time of diagnosis

The interaction between exercise and neurofilament light chain in multiple sclerosis: a systematic review and meta-analysis

Serum Neurofilaments are a reliable biomarker to early detect PML in Multiple Sclerosis patients

Evaluating the utility of serum NfL, GFAP, UCHL1 and tTAU as estimates of CSF levels and diagnostic instrument in neuroinflammation and multiple sclerosis

The weak association between neurofilament levels at multiple sclerosis onset and cognitive performance after 9 years

Aktive Filter

Suchergebnisse filtern